May 17 (Reuters) - Biopharmaceutical company Rapport Therapeutics, backed by the venture capital arm of Johnson & Johnson (JNJ.N), opens new tab, filed for an initial public offering in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback